(Reuters) - The U.S. Food and Drug Administration approved Zevra Therapeutics' drug for a rare and fatal genetic disorder, the first treatment to get a nod for the condition, the health regulator said on Friday.

(Reporting by Sriparna Roy and Kashish Tandon in Bengaluru; Editing by Devika Syamnath)